Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.29 USD | +0.99% | +16.14% | +62.65% |
May. 09 | Verastem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.65% | 333M | |
+7.72% | 111B | |
+11.13% | 106B | |
-12.18% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.73% | 16.81B | |
+38.60% | 12.54B | |
-24.51% | 8.09B |
- Stock Market
- Equities
- VSTM Stock
- News Verastem, Inc.
- Verastem Gets Orphan Drug Designation From US FDA for Avutometinib to Treat Type of Ovarian Cancer